Aier Eye Hospital Stock Soars 7.5%, Hits Intraday High of CNY 8.67

Aier Eye Hospital Group Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.5% on June 29, 2026. The stock reached an intraday high of CNY 8.67, marking a notable moment in its trading activity. This performance stands in contrast to the China Shanghai Composite, which only saw a 1.16% increase on the same day. Despite this daily gain, Aier Eye Hospital's longer-term performance reveals a more complex picture. Over the past year, the stock has declined by 30.65%, and its year-to-date performance shows a decrease of 21.68%. The company has faced challenges, with profits falling by 3.2% over the last year, even as it reported a net profit growth of 12.46% in its latest results. Key financial metrics indicate a market capitalization of CNY 66,109 million and a price-to-earnings ratio of 18.00. The company also boasts a high dividend yield of 3.22%, alongside a return on equity of 15.58%. However, Aier Eye Hospital has consistently underperformed against the benchmark over the last three years, highlighting the complexities of its market position within the pharmaceuticals and biotechnology industry.